A study found that 26% of uncertainties in cancer drug approvals are not included in FDA labels, with 48% being crucial to approval decisions. The FDA's current communication methods, such as drug ...

These results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions." A majority of cancer drugs approved in the US ...

On July 19, 2024, a single-digit error in the software update of cybersecurity company CrowdStrike grounded international airlines, halted emergency medical ...

Please provide your email address to receive an email when new articles are posted on . The FDA frequently identifies uncertainties about newly approved cancer drugs, but they are often omitted in ...

FDA reviewers flagged trial uncertainties for nearly 80% of cancer drugs approved from 2019 to 2022, but few were reported in journals or National Comprehensive Cancer Network (NCCN) guidelines. The ...

The International Accounting Standards Board published a consultation document Wednesday with eight proposed illustrative examples showing how companies could apply International Financial Reporting ...